RecruitingNCT06936449

Long-term Follow-up of a Cochlear Implant With Dexamethasone Eluting Electrode Array

Long-term Follow-up of a Cohort of Adult CI632D and CI632 Participants in the CLTD5759 CI-DEX Study


Sponsor

Cochlear

Enrollment

19 participants

Start Date

May 5, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

A long-term follow-up of Cochlear's cochlear implant electrode array which passively elutes dexamethasone for a defined period of time to help reduce inflammatory responses.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called CI632 and a medical device called CI632D for people with bilateral hearing loss and sensorineural hearing loss. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICECI632D

CI632 cochlear implant with Slim Modiolar electrode including dexamethasone in the electrode within wells

DEVICECI632

CI632 cochlear implant with Slim Modiolar electrode with market approval and does not include dexamethasone


Locations(3)

Rocky Mountain Ear Center

Englewood, Colorado, United States

University of Iowa

Iowa City, Iowa, United States

University Hospitals Cleveland

Cleveland, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06936449


Related Trials